Production of interferon MCQs With Answer
This quiz set focuses on the production, processing, characterization and regulatory considerations of interferons as relevant to M.Pharm students specializing in Advanced Pharmaceutical Biotechnology. It covers recombinant expression platforms (bacterial, yeast, insect and mammalian), upstream bioreactor strategies, secretion and refolding approaches, downstream purification and viral/endotoxin clearance, analytical and potency assays, post‑translational modifications such as glycosylation and pegylation, and critical quality attributes. The questions are designed to test conceptual understanding and practical decision‑making encountered during scale‑up and manufacture of interferon therapeutics, emphasizing deeper process and product-related knowledge rather than superficial facts.
Q1. Which of the following is classified as a Type II interferon?
- Interferon-alpha
- Interferon-beta
- Interferon-gamma
- Interferon-lambda
Correct Answer: Interferon-gamma
Q2. Historically, which host has been most commonly used for large‑scale recombinant production of clinical interferon-alpha (e.g., IFN alfa-2b)?
- Pichia pastoris yeast
- Escherichia coli
- Chinese hamster ovary (CHO) cells
- Baculovirus-infected insect cells
Correct Answer: Escherichia coli
Q3. What is the major biochemical problem encountered when expressing human interferon in E. coli that often necessitates downstream refolding?
- Hyper‑glycosylation in the cytosol
- Formation of inclusion bodies containing aggregated protein
- Excessive disulfide bond formation in the periplasm
- Proteolytic hyper‑cleavage producing unstable fragments
Correct Answer: Formation of inclusion bodies containing aggregated protein
Q4. Which promoter is commonly used in Pichia pastoris for high‑level methanol‑induced expression of recombinant interferon?
- GAP (constitutive glyceraldehyde‑3‑phosphate dehydrogenase) promoter
- AOX1 (alcohol oxidase 1) promoter
- CMV (cytomegalovirus) promoter
- lac promoter
Correct Answer: AOX1 (alcohol oxidase 1) promoter
Q5. Which affinity tag and corresponding purification method is most commonly used to simplify recombinant interferon purification?
- GST tag with glutathione affinity chromatography
- FLAG tag with anti‑FLAG immunoaffinity chromatography
- 6xHis tag with immobilized metal affinity chromatography (IMAC)
- Maltose binding protein (MBP) with amylose resin
Correct Answer: 6xHis tag with immobilized metal affinity chromatography (IMAC)
Q6. Why is pegylation commonly applied to therapeutic interferons?
- To increase receptor binding affinity and potency
- To reduce half‑life and accelerate clearance
- To increase serum half‑life and reduce immunogenicity
- To add glycosylation patterns identical to human cells
Correct Answer: To increase serum half‑life and reduce immunogenicity
Q7. Which assay is routinely used to determine the biological potency of interferon preparations and reported in International Units (IU)?
- ELISA for interferon concentration (ng/mL)
- Antiviral bioassay measuring protection against viral cytopathic effect
- SDS‑PAGE densitometry for purity assessment
- Mass spectrometry for molecular mass determination
Correct Answer: Antiviral bioassay measuring protection against viral cytopathic effect
Q8. How does glycosylation typically affect interferon therapeutic proteins?
- It always decreases biological activity by steric hindrance
- It has no effect on stability or receptor interactions
- It can modulate stability, circulating half‑life and receptor binding
- It converts interferon into a protease
Correct Answer: It can modulate stability, circulating half‑life and receptor binding
Q9. Which downstream technique is specifically useful for reducing endotoxin levels in interferon produced from E. coli?
- Protein A affinity chromatography
- Triton X‑114 phase separation
- Size exclusion chromatography as the only step
- Lyophilization
Correct Answer: Triton X‑114 phase separation
Q10. For production of a glycosylated form of interferon-beta with human‑like N‑glycans, which expression system is preferred?
- Escherichia coli cytosolic expression
- Pichia pastoris with AOX1 promoter
- Mammalian cells such as CHO
- Baculovirus expression in insect cells
Correct Answer: Mammalian cells such as CHO
Q11. What is a commonly used method to recover biologically active interferon from inclusion bodies?
- Direct injection without processing
- Stepwise dialysis or controlled dilution refolding into refolding buffer
- Heating to 95°C to solubilize aggregates
- Treatment with glycosyltransferases
Correct Answer: Stepwise dialysis or controlled dilution refolding into refolding buffer
Q12. What is the principal role of adding a signal peptide to a recombinant interferon expression construct for secretion?
- To increase translation speed in the cytosol
- To direct the protein to the secretory pathway for periplasmic/ER translocation and disulfide bond formation
- To tag the protein for proteasomal degradation
- To add glycosylation sites directly in the signal peptide
Correct Answer: To direct the protein to the secretory pathway for periplasmic/ER translocation and disulfide bond formation
Q13. Which analytical technique provides an estimate of interferon purity and apparent molecular weight under denaturing conditions?
- Size exclusion HPLC exclusively
- SDS‑PAGE with Coomassie staining
- Biacore surface plasmon resonance
- Endotoxin assay
Correct Answer: SDS‑PAGE with Coomassie staining
Q14. Type I interferons (e.g., IFN‑alpha and IFN‑beta) exert their effects by binding to which receptor complex?
- IFNGR1/IFNGR2 complex
- IFNAR1/IFNAR2 complex
- IL‑2 receptor alpha/beta
- Toll‑like receptor 4 (TLR4)
Correct Answer: IFNAR1/IFNAR2 complex
Q15. Which bioreactor cultivation strategy is most suitable for continuous high volumetric productivity and minimal product residence time to reduce proteolysis of secreted interferon from mammalian cells?
- Batch culture with single harvest at end
- Fed‑batch culture
- Perfusion culture with continuous harvest
- Static flask culture
Correct Answer: Perfusion culture with continuous harvest
Q16. Which single upstream culture parameter most directly influences glycosylation microheterogeneity of recombinant interferon made in mammalian cells?
- Culture pH
- Cell line passage number only
- Antifoam concentration
- Type of stirrer blade
Correct Answer: Culture pH
Q17. What is the main purpose of codon optimization when designing an interferon gene for expression in a heterologous host?
- To introduce new glycosylation sites
- To match host tRNA abundance and improve translation efficiency
- To alter the protein primary sequence and function
- To add disulfide bonds to the protein
Correct Answer: To match host tRNA abundance and improve translation efficiency
Q18. Which regulatory concern is particularly critical for interferon produced in bacterial hosts compared with mammalian hosts?
- Excessive human‑like glycosylation
- Endotoxin contamination
- Viral contaminants from human cell lines
- Over‑glycosylation leading to aggregation
Correct Answer: Endotoxin contamination
Q19. How is specific biological activity of an interferon preparation most commonly expressed?
- mg/mL concentration by UV absorbance
- International Units per mg (IU/mg) determined by bioassay
- Number of disulfide bonds per molecule
- Ratio of glycoforms by mass spectrometry
Correct Answer: International Units per mg (IU/mg) determined by bioassay
Q20. Which downstream unit operation is a standard viral clearance method used for removal of potential adventitious viruses during interferon purification?
- Ion exchange chromatography only
- Nanofiltration (virus‑retentive filtration)
- Dialysis against PBS
- Ultracentrifugation without membrane filtration
Correct Answer: Nanofiltration (virus‑retentive filtration)

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com
